Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Glatiramer acetate treatment normalizes deregulated microRNA expression in relapsing remitting multiple sclerosis.
Dynamic regulatory network controlling TH17 cell differentiation.
Good Early Results for HERV Suppressor in MS
Glatiramer acetate-induced acute hepatotoxicity in an adolescent with MS.
PI(3,5)P2 biosynthesis regulates oligodendrocyte differentiation by intrinsic and extrinsic mechanisms.
In vivo gene expression revealed by cDNA arrays: the pattern in relapsing-remitting multiple sclerosis patients compared with normal subjects.
Long-term Safety, Tolerability and Efficacy of BAF312 Given Orally in Patients With Relapsing-remitting Multiple Sclerosis
Quantitative assays for anti-aquaporin-4 antibody with subclass analysis in neuromyelitis optica.
Remyelination therapy goes to trial for multiple sclerosis
Environmental risk factors for multiple sclerosis. Part I: the role of infection.
The effect of vitamin a supplementation on biochemical parameters in multiple sclerosis patients.
Multiple sclerosis: an immune or neurodegenerative disorder?
Reduction of disease activity and disability with high-dose cyclophosphamide in patients with aggressive multiple sclerosis.
Genmab Announces Ofatumumab Development Plans in RRMS and NMO
Assessment of Disease Activity in Multiple Sclerosis Phenotypes with Combined Gadolinium- and Superparamagnetic Iron Oxide-enhanced MR Imaging.
Diminished Th17 (not Th1) responses underlie multiple sclerosis disease abrogation after hematopoietic stem cell transplantation.
Cutting Edge: Integrin α4 Is Required for Regulatory B Cell Control of Experimental Autoimmune Encephalomyelitis.
4-aminopyridine toxicity: a case report and review of the literature.
Volumetric comparisons of supratentorial white matter hyperintensities on FLAIR MRI in patients with migraine and multiple sclerosis.
Immune status following alemtuzumab treatment in human CD52 transgenic mice.
Antiinflammatory effects of orientin-2″-o-galactopyranoside on lipopolysaccharide-stimulated microglia.
Tip variant focal segmental glomerulosclerosis associated with interferon-β treatment of multiple sclerosis.
Generation and Characterization of Fully Human Monoclonal Antibodies Against Human Orai1 for Autoimmune Disease.
[Evaluation and quantification of spasticity: a review of the clinical, biomechanical and neurophysiological methods].
Treatment of Relapsing-Remitting Multiple Sclerosis After 24 Doses of Natalizumab: Evidence From an Italian Spontaneous, Prospective, and Observational Study (the TY-STOP Study).

Pages